Tolerability Profile
ZYRTEC® provides symptom relief that’s generally well tolerated1
In clinical trials of children ages 6 to 11 years
- 4.2% of patients taking ZYRTEC® 10 mg reported somnolence (n=215) vs 1.3% with placebo (n=309)1
- ≤1% of ZYRTEC® patients discontinued due to somnolence1


Learn more about Children's ZYRTEC®


Patient resources for allergy care
Help patients understand and better manage their allergies with these valuable resources.

Caregiver Brochure
Help educate children and caregivers about allergies with an educational brochure and storybook.

